Tracked deals
8
8 tracked deals across 2019-2026.
Public Company
Healthcare
Labcorp
Burlington, North Carolina, United States
World’s leading health care diagnostics company providing comprehensive clinical laboratory testing and end-to-end drug development services through LabCorp Diagnostics and Covance Drug Development.
- Focus Areas
- Clinical Diagnostics, Drug Development (CRO), Laboratory Services
- Website
- www.labcorp.com
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Buyout
6 buyout · 2 divestiture
Labcorp Acquisition Volume by Year
Last 6 years
Actual
Full-year estimate
Supporting Data
Recent Transactions
-
September 8, 2026
- Buyer
- Labcorp
- Target
- MLM Medical Labs
- Seller
- Great Point Partners
- Industry
- Healthcare Services
- Location
- Germany
- Type
- Buyout
Labcorp announced it has acquired MLM Medical Labs (MLM), a global central and specialty laboratory provider with operations in the United States, Germany, and South Africa. The deal expands Labcorp’s wholly owned central laboratory network across four continents and strengthens biomarker and specialty testing capabilities for clinical trials; financial terms were not disclosed.
-
April 21, 2025
- Buyer
- Labcorp
- Target
- North Mississippi Health Services (Ambulatory Outreach Laboratory Business)
- Seller
- North Mississippi Health Services
- Industry
- Healthcare Services
- Location
- Mississippi, United States
- Type
- Divestiture
Labcorp has completed the acquisition of North Mississippi Health Services' ambulatory outreach laboratory business and will become the referral laboratory for NMHS's seven hospitals and clinic laboratories. Labcorp plans to open three new patient service centers in Tupelo, West Point and Amory to increase access to laboratory services and provide continuity of care, data tools and expanded testing capabilities in North Mississippi.
-
October 30, 2024
- Buyer
- Labcorp, Ephios Bidco GmbH, Elliott Advisors (UK) Limited
- Target
- SYNLAB AG
- Seller
- Cinven, Elliott Advisors (UK) Limited
- Industry
- Healthcare Services
- Location
- Bavaria, Germany
- Type
- Divestiture
Cinven has sold an indirect minority stake in SYNLAB to strategic investor Labcorp while funds advised by Elliott have agreed to sell their direct stake to Ephios Bidco (Cinven-controlled) and reinvest proceeds to become an indirect minority shareholder alongside Cinven, Labcorp and Qatar Holding. The transactions leave Cinven as majority shareholder of SYNLAB and create opportunities for collaboration (including bringing Labcorp specialty tests to Europe); the Elliott transaction remains subject to regulatory approvals and is expected to close in early 2025.
-
- Buyer
- Dynacare (a Labcorp company)
- Target
- Valley Medical Laboratories
- Industry
- Healthcare Services
- Location
- British Columbia, Canada
- Type
- Buyout
Dynacare, a Labcorp subsidiary, has agreed to acquire Valley Medical Laboratories effective May 1, 2023. The acquisition adds Valley Medical’s network of 14 patient service locations and more than 150 staff in the Okanagan Valley, expanding Dynacare’s diagnostic and community laboratory presence in British Columbia.
-
November 18, 2021
- Buyer
- Labcorp
- Target
- Toxikon Corporation
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Type
- Buyout
Labcorp has acquired Toxikon Corporation, a Bedford, Massachusetts-based contract research organization that provides nonclinical in vivo and in vitro testing for pharmaceutical, biotech and medical device clients. The acquisition expands Labcorp Drug Development's nonclinical testing capabilities and creates a strategic Boston-area footprint; Toxikon reported approximately $40 million in annual revenue and the deal closed in December 2021.
-
August 12, 2021
- Buyer
- Labcorp
- Target
- Ovia Health
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Type
- Buyout
Labcorp acquired Ovia Health, a digital women's health platform that supports family planning, pregnancy and parenting, to expand its women's health capabilities and digital offerings. The acquisition builds on a prior strategic investment from Labcorp's Venture Fund and aims to combine Labcorp's diagnostics and genetics expertise with Ovia's digital platform to improve patient experience and outcomes; terms were not disclosed.
-
- Buyer
- Datavant, New Mountain Capital, Sixth Street, Goldman Sachs Asset Management, Roivant Sciences, Transformation Capital, Merck Global Health Innovation Fund, Labcorp, Cigna Ventures, Johnson & Johnson Innovation – JJDC, Inc., Flex Capital
- Target
- Ciox Health
- Industry
- Data & Analytics
- Location
- Georgia, United States
- Type
- Buyout
Datavant and Ciox Health signed a definitive agreement to merge in a transaction valued at $7.0 billion, creating a combined company to be named Datavant that will be the largest neutral health data ecosystem in the United States. The deal is supported by an investor group led by New Mountain Capital with significant new investment from Sixth Street and participation from Goldman Sachs Asset Management, Roivant Sciences and other strategic and financial investors; upon closing Pete McCabe will be CEO and Travis May will be President.
-
March 4, 2019
- Buyer
- LabCorp
- Target
- MNG Laboratories
- Seller
- HealthEdge Investment Partners
- Industry
- Healthcare Services
- Location
- Georgia, United States
- Type
- Buyout
LabCorp has acquired MNG Laboratories, an Atlanta-based clinical diagnostic provider specializing in neurogenetics and next-generation sequencing, from HealthEdge Investment Partners' Fund II. The acquisition expands LabCorp’s neurology and neurogenetics testing capabilities and makes MNG’s testing services available through LabCorp’s Covance drug development business.
Related Acquisition Pages
Healthcare Services Buyers & Acquisitions
7 tracked deals by Labcorp.
Data & Analytics Buyers & Acquisitions
1 tracked deal by Labcorp.
Acquisitions in Georgia
2 tracked deals by Labcorp.
Acquisitions in Massachusetts
2 tracked deals by Labcorp.
Acquisitions in Mississippi
1 tracked deal by Labcorp.
Selling a company? Get in front of buyers like Labcorp
Turn tracked acquisition activity into an outreach-ready buyer list.